{"transactions":[{"id":712239,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31326,"kind":"person","name":"O'Malley Brendan M.","position":1,"cik":"0001884342","reported_name":"O'Malley Brendan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-07-09T23:20:04.000Z","date":"2026-07-09","kind":"sale","planned":false,"acquired":false,"shares":12050,"price":6.9637,"value":83912.585,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.86 to $7.04 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":427953,"source":{"system":"sec-edgar","filing":"0001493152-26-032742","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226032742/ownership.xml","form_type":"4"}},{"id":745560,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31326,"kind":"person","name":"O'Malley Brendan M.","position":1,"cik":"0001884342","reported_name":"O'Malley Brendan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-06-10T00:32:56.000Z","date":"2026-06-09","kind":"sale","planned":false,"acquired":false,"shares":6305,"price":5.3042,"value":33442.981,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.24 to $5.47 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":440003,"source":{"system":"sec-edgar","filing":"0001493152-26-028019","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226028019/ownership.xml","form_type":"4"}},{"id":745559,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31326,"kind":"person","name":"O'Malley Brendan M.","position":1,"cik":"0001884342","reported_name":"O'Malley Brendan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-06-10T00:32:56.000Z","date":"2026-06-08","kind":"sale","planned":false,"acquired":false,"shares":4826,"price":5.4295,"value":26202.767,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.345 to $5.54 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":446308,"source":{"system":"sec-edgar","filing":"0001493152-26-028019","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226028019/ownership.xml","form_type":"4"}},{"id":933854,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31326,"kind":"person","name":"O'Malley Brendan M.","position":1,"cik":"0001884342","reported_name":"O'Malley Brendan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-01-23T01:33:50.000Z","date":"2026-01-22","kind":"sale","planned":false,"acquired":false,"shares":13578,"price":5.3309,"value":72382.9602,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.33 to $5.38 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":451134,"source":{"system":"sec-edgar","filing":"0001493152-26-003282","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226003282/ownership.xml","form_type":"4"}},{"id":936516,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31326,"kind":"person","name":"O'Malley Brendan M.","position":1,"cik":"0001884342","reported_name":"O'Malley Brendan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-01-20T21:30:20.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":113949,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock will vest one-third on each of January 20, 2027, January 20, 2028, and January 20, 2029."}],"balance_after":464712,"source":{"system":"sec-edgar","filing":"0001493152-26-002885","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226002885/ownership.xml","form_type":"4"}},{"id":1030111,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31326,"kind":"person","name":"O'Malley Brendan M.","position":1,"cik":"0001884342","reported_name":"O'Malley Brendan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-10-01T20:30:13.000Z","date":"2025-09-29","kind":"sale","planned":false,"acquired":false,"shares":9366,"price":5.3935,"value":50515.521,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.35 to $5.46 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":350763,"source":{"system":"sec-edgar","filing":"0001493152-25-016544","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315225016544/ownership.xml","form_type":"4"}},{"id":1035225,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31326,"kind":"person","name":"O'Malley Brendan M.","position":1,"cik":"0001884342","reported_name":"O'Malley Brendan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-09-22T23:49:23.000Z","date":"2025-09-22","kind":"sale","planned":false,"acquired":false,"shares":688,"price":5.43,"value":3735.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards."}],"balance_after":360129,"source":{"system":"sec-edgar","filing":"0001493152-25-014527","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315225014527/ownership.xml","form_type":"4"}},{"id":1089818,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31326,"kind":"person","name":"O'Malley Brendan M.","position":1,"cik":"0001884342","reported_name":"O'Malley Brendan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-07-10T20:30:30.000Z","date":"2025-07-09","kind":"sale","planned":false,"acquired":false,"shares":17428,"price":5.8557,"value":102053.1396,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.78 to $5.92 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":360817,"source":{"system":"sec-edgar","filing":"0001641172-25-018601","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000164117225018601/ownership.xml","form_type":"4"}},{"id":1120519,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31326,"kind":"person","name":"O'Malley Brendan M.","position":1,"cik":"0001884342","reported_name":"O'Malley Brendan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2025-06-06T21:56:52.000Z","date":"2025-06-06","kind":"sale","planned":false,"acquired":false,"shares":10470,"price":6.76,"value":70777.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.76 to $6.79 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":378245,"source":{"system":"sec-edgar","filing":"0001641172-25-014167","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000164117225014167/ownership.xml","form_type":"4"}},{"id":1233254,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31326,"kind":"person","name":"O'Malley Brendan M.","position":1,"cik":"0001884342","reported_name":"O'Malley Brendan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2025-03-04T21:30:06.000Z","date":"2025-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":181,"price":5.24,"value":948.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of restricted stock surrendered to satisfy the reporting person's tax withholding obligation upon vesting of restricted stock. The deemed disposition of the withheld shares is exempt pursuant to Rule 16b-3(e)."}],"balance_after":388715,"source":{"system":"sec-edgar","filing":"0001493152-25-009056","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315225009056/ownership.xml","form_type":"4"}},{"id":1297028,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31326,"kind":"person","name":"O'Malley Brendan M.","position":1,"cik":"0001884342","reported_name":"O'Malley Brendan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2025-01-23T23:58:34.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":115607,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock will vest one-third on each of January 21, 2026, January 21, 2027 and January 21, 2028."}],"balance_after":388896,"source":{"system":"sec-edgar","filing":"0001493152-25-003465","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315225003465/ownership.xml","form_type":"4"}},{"id":1398217,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31326,"kind":"person","name":"O'Malley Brendan M.","position":1,"cik":"0001884342","reported_name":"O'Malley Brendan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2024-09-30T20:30:34.000Z","date":"2024-09-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":6579,"price":5.89,"value":38750.31,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of restricted stock surrendered to satisfy the reporting person's tax withholding obligation upon vesting of restricted stock. The deemed disposition of the withheld shares is exempt pursuant to Rule 16b-3(e)."}],"balance_after":273289,"source":{"system":"sec-edgar","filing":"0001493152-24-038800","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315224038800/ownership.xml","form_type":"4"}},{"id":1400612,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31326,"kind":"person","name":"O'Malley Brendan M.","position":1,"cik":"0001884342","reported_name":"O'Malley Brendan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2024-09-24T20:30:07.000Z","date":"2024-09-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":496,"price":6.02,"value":2985.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of restricted stock surrendered to satisfy the reporting person's tax withholding obligation upon vesting of restricted stock.\nThe deemed disposition of the withheld shares is exempt pursuant to Rule 16b-3(e)."}],"balance_after":279868,"source":{"system":"sec-edgar","filing":"0001493152-24-037961","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315224037961/ownership.xml","form_type":"4"}},{"id":1458011,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31326,"kind":"person","name":"O'Malley Brendan M.","position":1,"cik":"0001884342","reported_name":"O'Malley Brendan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common stock","published_at":"2024-07-09T20:35:40.000Z","date":"2024-07-08","kind":"grant","planned":false,"acquired":true,"shares":102689,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock will vest one-third on each of July 8, 2025, July 8, 2026 and July 8, 2027."}],"balance_after":280364,"source":{"system":"sec-edgar","filing":"0001493152-24-026646","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315224026646/ownership.xml","form_type":"4"}},{"id":1487727,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31326,"kind":"person","name":"O'Malley Brendan M.","position":1,"cik":"0001884342","reported_name":"O'Malley Brendan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common stock","published_at":"2024-06-07T20:31:10.000Z","date":"2024-06-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":10951,"price":4.52,"value":49498.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of restricted stock surrendered to satisfy the reporting person's tax withholding obligation upon vesting of restricted stock. The deemed disposition of the withheld shares is exempt pursuant to Rule 16b-3(e)."}],"balance_after":177675,"source":{"system":"sec-edgar","filing":"0001493152-24-023122","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315224023122/ownership.xml","form_type":"4"}},{"id":1487726,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31326,"kind":"person","name":"O'Malley Brendan M.","position":1,"cik":"0001884342","reported_name":"O'Malley Brendan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common stock","published_at":"2024-06-07T20:30:33.000Z","date":"2024-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":92,"price":7.25,"value":667.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of restricted stock surrendered to satisfy the reporting person's tax withholding obligation upon vesting of restricted stock. The deemed disposition of the withheld shares is exempt pursuant to Rule 16b-3(e)."}],"balance_after":180026,"source":{"system":"sec-edgar","filing":"0001493152-24-023117","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315224023117/ownership.xml","form_type":"4"}},{"id":1535064,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31326,"kind":"person","name":"O'Malley Brendan M.","position":1,"cik":"0001884342","reported_name":"O'Malley Brendan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common stock","published_at":"2024-04-26T12:30:36.000Z","date":"2024-04-25","kind":"purchase","planned":false,"acquired":true,"shares":8600,"price":3.24,"value":27864.0,"ownership":{"direct":true},"balance_after":188718,"source":{"system":"sec-edgar","filing":"0001493152-24-016064","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315224016064/ownership.xml","form_type":"4"}},{"id":1582868,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31326,"kind":"person","name":"O'Malley Brendan M.","position":1,"cik":"0001884342","reported_name":"O'Malley Brendan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common stock","published_at":"2024-03-12T21:00:30.000Z","date":"2024-03-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":183,"price":7.81,"value":1429.23,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of restricted stock surrendered to satisfy the reporting person's tax withholding obligation upon vesting of restricted stock. The deemed disposition of the withheld shares is exempt pursuant to Rule 16b-3(e)."}],"balance_after":180118,"source":{"system":"sec-edgar","filing":"0001493152-24-009682","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315224009682/ownership.xml","form_type":"4"}},{"id":1771882,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31326,"kind":"person","name":"O'Malley Brendan M.","position":1,"cik":"0001884342","reported_name":"O'Malley Brendan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common stock","published_at":"2023-09-29T21:16:37.000Z","date":"2023-09-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":6557,"price":3.93,"value":25769.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of restricted stock surrendered to satisfy the reporting person's tax withholding obligation upon vesting of restricted stock. The deemed disposition of the withheld shares is exempt pursuant to Rule 16b-3(e)."}],"balance_after":180301,"source":{"system":"sec-edgar","filing":"0001493152-23-034903","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315223034903/ownership.xml","form_type":"4"}},{"id":1775110,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31326,"kind":"person","name":"O'Malley Brendan M.","position":1,"cik":"0001884342","reported_name":"O'Malley Brendan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common stock","published_at":"2023-09-22T20:05:30.000Z","date":"2023-09-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":563,"price":3.8,"value":2139.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of restricted stock surrendered to satisfy the reporting person's tax withholding obligation upon vesting of restricted stock. The deemed disposition of the withheld shares is exempt pursuant to Rule 16b-3(e)."}],"balance_after":186858,"source":{"system":"sec-edgar","filing":"0001493152-23-033448","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315223033448/ownership.xml","form_type":"4"}},{"id":1778355,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31326,"kind":"person","name":"O'Malley Brendan M.","position":1,"cik":"0001884342","reported_name":"O'Malley Brendan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common stock","published_at":"2023-09-19T13:00:06.000Z","date":"2023-09-18","kind":"purchase","planned":false,"acquired":true,"shares":3000,"price":3.8,"value":11400.0,"ownership":{"direct":true},"balance_after":187421,"source":{"system":"sec-edgar","filing":"0001493152-23-033000","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315223033000/ownership.xml","form_type":"4"}},{"id":1864606,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31326,"kind":"person","name":"O'Malley Brendan M.","position":1,"cik":"0001884342","reported_name":"O'Malley Brendan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common stock","published_at":"2023-06-07T20:15:35.000Z","date":"2023-06-05","kind":"grant","planned":false,"acquired":true,"shares":90902,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock will vest one-third on each of June 5, 2024, June 5, 2025 and June 5, 2026."}],"balance_after":184421,"source":{"system":"sec-edgar","filing":"0001493152-23-020415","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315223020415/ownership.xml","form_type":"4"}},{"id":1926093,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31326,"kind":"person","name":"O'Malley Brendan M.","position":1,"cik":"0001884342","reported_name":"O'Malley Brendan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common stock","published_at":"2023-04-05T20:23:20.000Z","date":"2023-04-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":104,"price":2.82,"value":293.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of restricted stock surrendered to satisfy the reporting person's tax withholding obligation upon vesting of restricted stock. The deemed disposition of the withheld shares is exempt pursuant to Rule 16b-3(e)."}],"balance_after":93519,"source":{"system":"sec-edgar","filing":"0001493152-23-011036","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315223011036/ownership.xml","form_type":"4"}},{"id":1977145,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31326,"kind":"person","name":"O'Malley Brendan M.","position":1,"cik":"0001884342","reported_name":"O'Malley Brendan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common stock","published_at":"2023-03-04T00:00:03.000Z","date":"2023-03-03","kind":"tax_withholding","acquired":false,"shares":207,"price":2.28,"value":471.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of restricted stock surrendered to satisfy the reporting person's tax withholding obligation upon vesting of restricted stock. The deemed disposition of the withheld shares is exempt pursuant to Rule 16b-3(e)."}],"balance_after":93623,"source":{"system":"sec-edgar","filing":"0001493152-23-006714","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315223006714/ownership.xml","form_type":"4"}},{"id":2090551,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31326,"kind":"person","name":"O'Malley Brendan M.","position":1,"cik":"0001884342","reported_name":"O'Malley Brendan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common stock","published_at":"2022-12-12T21:10:26.000Z","date":"2022-12-09","kind":"purchase","acquired":true,"shares":5869,"price":3.13,"value":18369.97,"ownership":{"direct":true},"balance_after":93830,"source":{"system":"sec-edgar","filing":"0001493152-22-035169","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315222035169/ownership.xml","form_type":"4"}},{"id":2109543,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31326,"kind":"person","name":"O'Malley Brendan M.","position":1,"cik":"0001884342","reported_name":"O'Malley Brendan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common stock","published_at":"2022-11-21T14:00:10.000Z","date":"2022-11-18","kind":"purchase","acquired":true,"shares":7500,"price":3.99,"value":29925.0,"ownership":{"direct":true},"balance_after":87961,"source":{"system":"sec-edgar","filing":"0001493152-22-033016","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315222033016/ownership.xml","form_type":"4"}},{"id":2149085,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31326,"kind":"person","name":"O'Malley Brendan M.","position":1,"cik":"0001884342","reported_name":"O'Malley Brendan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common stock","published_at":"2022-09-30T20:05:38.000Z","date":"2022-09-28","kind":"grant","acquired":true,"shares":72750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock will vest 25% on each of September 28, 2023, September 28, 2024, September 28, 2025 and September 28, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On September 22, 2022, the reporting person filed a Form 4 that inadvertently reported an additional 1,360 shares of common stock as beneficially owned in Column 5. The amount disclosed in Column 5 above rectifies that error."}],"balance_after":80461,"source":{"system":"sec-edgar","filing":"0001493152-22-027280","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315222027280/ownership.xml","form_type":"4"}},{"id":2153052,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31326,"kind":"person","name":"O'Malley Brendan M.","position":1,"cik":"0001884342","reported_name":"O'Malley Brendan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common stock","published_at":"2022-09-22T20:36:03.000Z","date":"2022-09-21","kind":"tax_withholding","acquired":false,"shares":479,"price":3.72,"value":1781.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock and does not represent a sale."}],"balance_after":9071,"source":{"system":"sec-edgar","filing":"0001493152-22-026569","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315222026569/ownership.xml","form_type":"4"}},{"id":2481408,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31326,"kind":"person","name":"O'Malley Brendan M.","position":1,"cik":"0001884342","reported_name":"O'Malley Brendan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common stock","published_at":"2021-12-09T00:05:10.000Z","date":"2021-12-06","kind":"sale","acquired":false,"shares":8880,"price":0.567,"value":5034.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Brendan O'Malley on February 24, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.56 to $0.59, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote."}],"balance_after":204750,"source":{"system":"sec-edgar","filing":"0001493152-21-030876","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221030876/ownership.xml","form_type":"4"}},{"id":2523910,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31326,"kind":"person","name":"O'Malley Brendan M.","position":1,"cik":"0001884342","reported_name":"O'Malley Brendan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common stock","published_at":"2021-11-05T23:00:12.000Z","date":"2021-11-05","kind":"sale","acquired":false,"shares":8880,"price":0.889,"value":7894.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Brendan O'Malley on February 24, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.8801 to $0.9038, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote."}],"balance_after":213630,"source":{"system":"sec-edgar","filing":"0001493152-21-027433","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221027433/ownership.xml","form_type":"4"}},{"id":2544011,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31326,"kind":"person","name":"O'Malley Brendan M.","position":1,"cik":"0001884342","reported_name":"O'Malley Brendan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common stock","published_at":"2021-10-13T23:08:46.000Z","date":"2021-10-11","kind":"sale","acquired":false,"shares":25734,"price":0.9043,"value":23271.2562,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan\nadopted by Brendan O'Malley on February 24, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were\nsold in multiple transactions at prices ranging from $0.89 to $0.9625, inclusive.\nThe reporting person undertakes to provide to the Issuer, any security holder,\nor the Staff of the SEC, upon request, full information regarding the number of\nshares disposed at each separate price within the ranges set forth in this\nfootnote."}],"balance_after":222510,"source":{"system":"sec-edgar","filing":"0001493152-21-025348","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221025348/ownership.xml","form_type":"4"}},{"id":2545916,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31326,"kind":"person","name":"O'Malley Brendan M.","position":1,"cik":"0001884342","reported_name":"O'Malley Brendan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common stock","published_at":"2021-10-09T00:31:59.000Z","date":"2021-10-08","kind":"sale","acquired":false,"shares":22763,"price":1.0506,"value":23914.8078,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Brendan O'Malley on February 24, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.84 to $1.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote."}],"balance_after":248244,"source":{"system":"sec-edgar","filing":"0001493152-21-025084","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221025084/ownership.xml","form_type":"4"}},{"id":2545915,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31326,"kind":"person","name":"O'Malley Brendan M.","position":1,"cik":"0001884342","reported_name":"O'Malley Brendan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common stock","published_at":"2021-10-09T00:31:59.000Z","date":"2021-10-05","kind":"sale","acquired":false,"shares":2447,"price":1.05,"value":2569.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Brendan O'Malley on February 24, 2021."}],"balance_after":271007,"source":{"system":"sec-edgar","filing":"0001493152-21-025084","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221025084/ownership.xml","form_type":"4"}},{"id":2562522,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31326,"kind":"person","name":"O'Malley Brendan M.","position":1,"cik":"0001884342","reported_name":"O'Malley Brendan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2021-09-22T21:37:34.000Z","date":"2021-09-20","kind":"grant","acquired":true,"shares":272000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest 25% on September 20, 2022, and in 36 equal monthly installments thereafter."}],"balance_after":272000,"derivative":{"exercise_price":1.21,"expiration_date":"2031-09-20","underlying":"Common Stock","underlying_shares":272000},"source":{"system":"sec-edgar","filing":"0001493152-21-023408","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221023408/ownership.xml","form_type":"4"}},{"id":2562521,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31326,"kind":"person","name":"O'Malley Brendan M.","position":1,"cik":"0001884342","reported_name":"O'Malley Brendan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common stock","published_at":"2021-09-22T21:37:34.000Z","date":"2021-09-20","kind":"grant","acquired":true,"shares":136000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock will vest 25% on each of September 20, 2022, September 20, 2023, September 20, 2024 and September 20, 2025."}],"balance_after":273454,"source":{"system":"sec-edgar","filing":"0001493152-21-023408","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221023408/ownership.xml","form_type":"4"}}]}